🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these profiles privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Social Networks

Separately, a flourishing market exists on messaging services, where communities with thousands of members share “before and after” images, administration instructions and claims of next-day British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Experts Voice Concerns

However, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.

Several professionals stated the popularity for the experimental drug could be linked to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some influencers try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or prison.

Service Response and Material Removal

According to the social media company, the platform has removed violative content and prohibited related keywords and query recommendations. The organization said it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also found communities with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, populated with images of slimming results, positive reviews and detailed instructions for preparing or administering at home.

Within moments of entering one group, a vendor posted WhatsApp details, where most transactions take place. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, health issues or past usage.

Item Information and Costs

Inside these groups, posts show dark colored packages with postal service stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service said it actively monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they cannot confirm. Although the research behind this drug is valid, these digital products may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has already encountered individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to potentially significant medical dangers”.